Switching tumor necrosis factor inhibitors: an opinion

被引：17
|
作者：
Keystone, Edward C.
机构：
[1] Mt Sinai Hosp, Rebecca MacDonald Ctr Arthrit & Autoimmune Dis, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2006年 / 2卷 / 11期
关键词：
D O I：
10.1038/ncprheum0339
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：576 / 577
页数：2
相关论文
共 50 条
  • [41] Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
    Peyrin-Biroulet, Laurent
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (26): : 2561 - 2561
  • [42] Trouble With Tumor Necrosis Factor α Inhibitors, Not Just Tuberculosis
    Racunica, Tina
    Cassidy, Dermot
    Cicuttini, Flavia M.
    Hall, Anthony
    ARTHRITIS CARE & RESEARCH, 2010, 62 (06) : 770 - 774
  • [43] Prescription analysis of tumor necrosis factor α inhibitors in Saxony
    Kasek, K
    Rolle, LM
    Benz, M
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2002, 12 (04): : 121 - 121
  • [44] Tumor necrosis factor inhibitors for rheumatoid arthritis - Reply
    Scott, D. L.
    Kingsley, G. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19): : 2048 - 2048
  • [45] Tumor necrosis factor inhibitors "SPARCC" an interest in consensus
    Sawitzke, A
    Clegg, DO
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (06) : 1127 - 1129
  • [46] Neurologic Toxicities Associated with Tumor Necrosis Factor Inhibitors and Calcineurin Inhibitors
    Coe, Christopher L.
    Horst, Sarah N.
    Izzy, Manhal J.
    NEUROLOGIC CLINICS, 2020, 38 (04) : 937 - 951
  • [47] Switching Tumor Necrosis Factor Alpha Antagonists in Patients with Scleritis
    Houser, Kourtney
    Leisy, Heather
    Huddleston, Stephen
    Walton, R. Christopher
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [48] EFFECT OF SWITCHING BETWEEN TUMOR NECROSIS FACTOR INHIBITOR IN SPONDYLOARTHRITIS
    ben Abla, Hedia
    Rekik, Sonia
    Boussaid, Soumaya
    Jammali, Samia
    Sahli, Hela
    Cheour, Elhem
    Elleuch, Mohamed
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1811 - 1811
  • [49] Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
    Cannon, Grant W.
    DuVall, Scott L.
    Haroldsen, Candace L.
    Caplan, Liron
    Curtis, Jeffrey R.
    Michaud, Kaleb
    Mikuls, Ted R.
    Reimold, Andreas
    Collier, David H.
    Joseph, George J.
    Harrison, David J.
    Sauer, Brian C.
    ADVANCES IN THERAPY, 2016, 33 (08) : 1347 - 1359
  • [50] Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
    Grant W. Cannon
    Scott L. DuVall
    Candace L. Haroldsen
    Liron Caplan
    Jeffrey R. Curtis
    Kaleb Michaud
    Ted R. Mikuls
    Andreas Reimold
    David H. Collier
    George J. Joseph
    David J. Harrison
    Brian C. Sauer
    Advances in Therapy, 2016, 33 : 1347 - 1359
12345